| 3,180 | 23 | 349 |
| 下载次数 | 被引频次 | 阅读次数 |
在"双循环"背景下,提升贸易便利化水平是推动中药国际化发展的重要途径。利用东盟国家2011—2017年的数据,创新性构建涵盖41个三级指标的贸易便利化综合评价指标体系,通过主成分分析测算东盟贸易便利化水平,并构建拓展的引力模型测算东盟贸易便利化对中国中药出口贸易的影响程度。结果表明,贸易便利化对中国中药出口有最大程度的促进作用,东盟贸易便利化水平每提高1%,中药出口贸易额将提高4.784%;四个一级指标回归系数大小依次为海关与边境管理(5.648)、基础保障与物流运输(4.343)、金融与电子商务(2.460)、政府管理与监管规制(1.715),这些指标均对中药出口贸易有显著正向影响。最后提出提高贸易便利化水平、促进中药贸易国际循环发展的对策建议,以促进中国—东盟中药贸易高质量发展。
Abstract：Against a background of "dual circulation", enhancing trade facilitation is an important way to promote the internationalization of traditional Chinese medicine(TCM). A comprehensive evaluation index system of trade facilitation with 41 three-level indicators was constructed based on the data of ASEAN countries from 2011 to 2017. First, the trade facilitation level of ASEAN was measured with principal component analysis method. Then, the calculation results were introduced into the constructed extended gravity model to perform regression analysis to measure the degree of the impact of ASEAN trade facilitation on China's export trade of TCM. The result showed that trade facilitation has the greatest effect on the export of TCM products, that is, if the ASEAN trade facilitation level is increased by 1%, the export volume of TCM products will increase by 4.784% provided other conditions remain unchanged. And the regression coefficients of the four first-level indicators of trade facilitation are R(5.648), T(4.343), C(2.460) and F(1.715) respectively, showing the positive impact on the export trade of TCM products. Finally, according to the analysis above, suggestions of improving the trade facilitation level and accelerating the TCM trade international circulation development were made to promote the high-quality development of China-ASEAN TCM product trade.
[1] 丁宏，战炤磊.“双循环”新格局下自贸区生物医药全产业链开放的逻辑与路径[J].现代经济探讨，2021,(4):83-88.
[2] Fu X.M,Zhang M.Q,Shao C.L,et al.Chinese Marine Materia Medica Resources:Status and Potential[J].Marine Drugs,2016,14(3):46.
[3] 谢伟.中药国际化竞争中专利价值实现的困境与进路——以新冠肺炎疫情、中美贸易摩擦、高价值内需为新契机[J].科技进步与对策，2022,39(3):69-76.
[4] Qi F.H and Tang W.Traditional Chinese medicine for treatment of novel infectious diseases:Current status and dilemma[J].BioScience Trends,2021,15(4):201-204.
[5] 张瑛，杜文婷.中国对东盟水产品贸易影响因素及发展潜力实证研究[J].中国海洋大学学报(社会科学版),2021,(1):90-100.
[6] 舒燕.我国面向“一带一路”沿线国家中药出口贸易格局的演变和影响因素研究[J].中国卫生经济，2021,40(11):68-72.
[7] 姚玲，申俊龙，李洁.基于进口鼓励国际化视野的中药资源“一带一路”国际贸易趋势研究[J].中草药，2019,50(14):3510-3516.
[8] 柳燕，于志斌.2019年中药类商品进出口形势分析[J].中国现代中药，2020,22(3):342-347.
[9] 曾倩，曾先峰，岳婧霞.东盟贸易便利化对中国出口贸易的影响[J].经济体制改革，2019,(2):187-194.
[10] Wilson J.S,Mann C.L,Otsuki T.Trade fcilitation and economic development:A New Approach to Measuring the Impact [J].World Bank Economic Review,2003(3):367-389.
[11] Shepherd B.,Wilson J.S.Trade facilitation in ASEAN member countries:Measuring progress and assessing priorities [J].Journal of Asian Economics,2009(4):367-383.
[12] Andreas E.R,Linda C.Trade facilitation,transport costs and the price of trucking services in East Africa [R].MPRA Paper 87150,2018.University Library of Munich,Germany.
[13] Shepherd B.,Dennis A.Trade Facilitation and Export Diversification [J].World Economy,2011(1):101-122.
[14] 汪戎，李波.贸易便利化与出口多样化：微观机理与跨国证据[J].国际贸易问题，2015,(3):33-43.
[15] 邓靖.贸易便利化、中间品进口与创新发展——基于“一带一路”沿线区域的实证检验[J].统计与决策，2021,37(12):145-149.
[16] 崔日明，陶文起.越南贸易便利化水平评估及对中国与越南贸易潜力的影响研究——基于“一带一路”背景[J].广西大学学报(哲学社会科学版),2019,41(2):107-114.
[17] 吴兆丹，华钰，丁小琦.“一带一路”国家贸易便利化对中国外贸的影响[J].华东经济管理，2020,34(3):53-58.
[18] 付秀梅，薛振凯，刘莹.“一带一路”背景下我国海洋生物医药产业发展研究[J].中国海洋大学学报(社会科学版),2019,(3):21-30.
[19] Koo J.,Arain S.Traditional Chinese Medicine for the Treatment of Dermatologic Disorders [J].Archives of Dermatology,1998(11):1388-1393.
[20] Nestler G.,Dovey M.Traditional Chinese medicine [J].Medical Clinics of North America,2002(1):63-73.
[21] Poon S.K,Goyal S.Cheng A.,Poon J.Searching for Evidence in Traditional Chinese Medicine Research:A Review and New Opportunities [J].Springer International Publishing,2014:1-16.
[22] Wang S,Van der Borght K,Song X.A Legal Analysiss on the Current Trade Status of Traditional Chinese Medicinal Product in the EU-from the Perspectives of WTO Law and EU Pharmaceutical Law [J].Asian Journal of WTO & International Health Law and Policy,2016,11(2):513-538.
[23] Li J,Zhu J,Hu H,et al.Internationalization of Traditional/Complementary Medicine products:market entry as medicine[J].Chinese Medicine,2018,13(1).
[24] Lin A X,Chan G,Hu Y,et al.Internationalization of traditional Chinese medicine:current international market,internationalization challenges and prospective suggestions[J].Chinese Medicine,2018,13(1).
[25] 程蒙，杨光，池秀莲，等.基于钻石理论的中药产业国际贸易竞争力研究[J].中国中药杂志，2019,44(1):199-203.
[26] 欧秀芳.中国中药产品出口现状分析[J].中国管理信息化，2019,22(4):144-145.
[27] 姜丽，霍卫.2013年上半年我国与东盟中药贸易分析[J].中国现代中药，2013,15(09):797-799.
[28] 刘娇，秦子楠，刘国秀，等.“一带一路”倡议下中医药贸易在东盟现状分析及发展策略思考[J].世界中医药，2021,16(11):1769-1774.
[29] 周艳，赵黎明.基于“一带一路”倡议的中药国际化路径选择[J].中草药，2020,51(22):5915-5920.
[30] 李爱玉，丰志培，邰蕾蕾.“一带一路”背景下中药产业发展路径研究[J].辽宁工业大学学报(社会科学版),2019,21(6):35-38.
[31] Wu P,Li J,Yan H.X,et al.Status and prospect of international standardization of TCM diagnosis[J].Pharmacological Research,2021,171:105746.
[32] 王硕，孟凡英，周瑛桃.“一带一路”背景下中药产品海外注册发展研究[J].世界中医药，2021,16(9):1497-1500.
[33] Wu H,Gong K,Qin Y,et al.In silico analysis of the potential mechanism of a preventive Chinese medicine formula on coronavirus disease 2019[J].Journal of Ethnopharmacology,2021,275:114098.
[34] Dai Y,Qiang W,Gui Y,et al.A large-scale transcriptional study reveals inhibition of COVID-19 related cytokine stormby traditional Chinese medicines[J].Science Bulletin,2021,66(9):884-888.
[35] 冯一帆，张青青.“一带一路”六大经济走廊贸易便利化测评报告(2013—2018)[J].人民论坛·学术前沿，2019,(19):64-91.
[36] 江瑶，高长春.“一带一路”贸易便利化对创意产品贸易出口的影响研究[J].国际商务(对外经济贸易大学学报),2018,(3):49-59.
[37] 孔庆峰，董虹蔚.“一带一路”国家的贸易便利化水平测算与贸易潜力研究[J].国际贸易问题，2015,(12):158-168.
[38] 徐胜，张双，唐佳婕，等.绿色金融促进海洋经济绿色转型的驱动效应研究[J].中国海洋大学学报(社会科学版),2019,(6):25-39.
[39] 朱晶，毕颖.贸易便利化对中国农产品出口深度和广度的影响——以“丝绸之路经济带”沿线国家为例[J].国际贸易问题，2018,(4):60-71.
[40] 余世琪.中国对东盟国家中成药出口的影响因素研究[D].北京：北京中医药大学，2018.
[41] 彭继增，张思娟，徐浩.文化距离对中国进出口贸易效率的影响——基于随机前沿引力模型的实证[J].统计与决策，2020,36(17):86-90.
[42] 胡霞，崔翔宇，叶雨昕，等.中国与“一带一路”沿线国家医药产品贸易潜力测算[J].统计与决策，2020,36(19):51-55.
[43] 刘钻扩，辛丽.21世纪海上丝绸之路贸易便利化对中国机电产品出口的影响——基于SYS-GMM的动态分析[J].统计与信息论坛，2019,34(6):58-66.
[44] 王莉莉.中医药国际合作融入“一带一路”建设[J].中国对外贸易，2021,(10):68-69.
(1)由于篇幅限制,本文未汇报各主成分的特征值、方差贡献率及累计方差贡献率,若有需要可向作者索取。
(2)参考柳燕和于志斌(2020)等学者对中药产品出口种类及海关编码的描述,经过拓展补充及对比分析,确定本文中药产品的6位HS海关编码:121110、121120、121130、121140、121150、121190为中药材及饮片,130211、130212、130213、130214、130219、330111、330112、330113、330119、330129、293890为植物提取物,0410、150410、150420、210690(0.046)为保健品,300490(0.130)为中成药,四种中药产品出口贸易总额表示中药产品出口贸易额。
基本信息:
DOI：10.16497/j.cnki.1672-335X.202202007
中图分类号:F752.62;F426.8;F753.3
引用信息:
[1]付秀梅,陈睿姝.“双循环”背景下东盟贸易便利化对中国中药出口贸易影响[J],2022,No.186(02):75-88.DOI:10.16497/j.cnki.1672-335X.202202007.
基金信息:
国家自然科学基金面上项目“海洋生物医药产业创新驱动机制与‘双循环’发展路径研究”(42176126);; 自然资源部海洋战略规划与经济司、中国海洋发展研究会项目“我国海洋生物医药产业发展新路径研究”(CAMA201817)